Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dual Anti-platelet Therapy”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Post-approval studies (Phase 4)Study completedNCT01659034
What this trial is testing

Short and Optimal Duration of Dual Antiplatelet Therapy Study

Who this might be right for
Coronary Artery Disease
Takeshi Morimoto 1,525
Not applicableEnded earlyNCT04885816
What this trial is testing

Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty

Who this might be right for
High Bleeding RiskCoronary Artery Disease (CAD)Percutaneous Coronary Intervention (PCI)
Instituto Nacional de Cardiologia Ignacio Chavez 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT06199089
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, and Multi-center Clinical Study of CM313 in the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 45
Large-scale testing (Phase 3)UnknownNCT01385319
What this trial is testing

Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Who this might be right for
Coronary Artery Disease
Marco Valgimigli 1,606
Not applicableNot Yet RecruitingNCT07140133
What this trial is testing

Dual Anti-Platelet Optimized Stent for High Bleeding Risk Patient

Who this might be right for
High Bleeding Risk PatientsCardiologyStent Implantation+1 more
University Hospital, Grenoble 1,200
Not applicableStudy completedNCT01134679
What this trial is testing

(EASY)-IMProving Adherence to Clopidogrel Trial (IMPACT))

Who this might be right for
Coronary Artery Disease
Laval University 300
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Not applicableStudy completedNCT01358422
What this trial is testing

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery

Who this might be right for
BleedingThrombosisCardiac Events
European Society of Anaesthesiology 830
Testing effectiveness (Phase 2)Study completedNCT01585259
What this trial is testing

Anfibatide Phase Ib-IIa Clinical Trial

Who this might be right for
Non-ST Segment Elevation Myocardial Infarction
Lee's Pharmaceutical Limited 90
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Post-approval studies (Phase 4)Study completedNCT03252249
What this trial is testing

Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

Who this might be right for
Acute Coronary SyndromeCoronary Artery Disease
University of Edinburgh 5,094
Post-approval studies (Phase 4)Not Yet RecruitingNCT07736196
What this trial is testing

Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)Dual Anti-platelet Therapy
Assiut University 300
Large-scale testing (Phase 3)Study completedNCT00269893
What this trial is testing

A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty

Who this might be right for
Angina, UnstableAngioplasty, Transluminal, Percutaneous Coronary
Centocor, Inc. 2,038
Post-approval studies (Phase 4)UnknownNCT00954707
What this trial is testing

CYPRESS - CYPHER for Evaluating Sustained Safety

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 2,509
Post-approval studies (Phase 4)Study completedNCT04483583
What this trial is testing

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Who this might be right for
Coronary Artery Disease
University of Florida 81
Not applicableStudy completedNCT03746782
What this trial is testing

Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation

Who this might be right for
Acute Coronary Syndrome
CirQuest Labs, LLC 40
Post-approval studies (Phase 4)Study completedNCT02118870
What this trial is testing

Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent

Who this might be right for
Acute Coronary Syndrome
Diagram B.V. 1,500
Not applicableStudy completedNCT00998127
What this trial is testing

Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients

Who this might be right for
Medication Non-adherenceStent Thrombosis
Icahn School of Medicine at Mount Sinai 5,031
Post-approval studies (Phase 4)Ended earlyNCT03224923
What this trial is testing

A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)

Who this might be right for
Stable Coronary SyndromePercutaneous Coronary InterventionAntiplatelet Therapy+1 more
Ottawa Heart Institute Research Corporation 5
Large-scale testing (Phase 3)Study completedNCT05070260
What this trial is testing

ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

Who this might be right for
Acute Ischemic Stroke
Acticor Biotech 438
Next Page